MAT2A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.928200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.074600E-01
Normal-vs-Stage2
8.664600E-01
Normal-vs-Stage3
8.398300E-03
Normal-vs-Stage4
1.828190E-01
Stage1-vs-Stage2
6.704200E-01
Stage1-vs-Stage3
1.779550E-02
Stage1-vs-Stage4
5.327800E-02
Stage2-vs-Stage3
2.247700E-04
Stage2-vs-Stage4
3.675700E-02
Stage3-vs-Stage4
5.100200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.480600E-01
Normal-vs-AfricanAmerican
3.417400E-01
Normal-vs-Asian
7.144600E-01
Caucasian-vs-AfricanAmerican
2.513400E-01
Caucasian-vs-Asian
3.067400E-01
AfricanAmerican-vs-Asian
7.133200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.833000E-01
Normal-vs-Female
9.017600E-01
Male-vs-Female
9.249600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.552200E-01
Normal-vs-Age(41-60Yrs)
9.285000E-01
Normal-vs-Age(61-80Yrs)
8.515400E-01
Normal-vs-Age(81-100Yrs)
7.263800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.002600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.903000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.785400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.745600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.118000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.050600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.664600E-01
Normal-vs-Daily Drinker
8.144600E-01
Normal-vs-Weekly Drinker
8.285600E-01
Normal-vs-Occasional Drinker
9.839800E-01
Normal-vs-Social Drinker
6.339400E-01
Non Drinker-vs-Daily Drinker
4.286000E-01
Non Drinker-vs-Weekly Drinker
8.202000E-01
Non Drinker-vs-Occasional Drinker
7.798000E-01
Non Drinker-vs-Social Drinker
4.943200E-01
Daily Drinker-vs-Weekly Drinker
5.021000E-01
Daily Drinker-vs-Occasional Drinker
6.903800E-01
Daily Drinker-vs-Social Drinker
1.669230E-01
Weekly Drinker-vs-Occasional Drinker
6.832400E-01
Weekly Drinker-vs-Social Drinker
8.082400E-01
Occasional Drinker-vs-Social Drinker
4.182600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.234400E-01
Normal-vs-Grade 2
2.200300E-02
Normal-vs-Grade 3
1.114590E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.844600E-01
Grade 1-vs-Grade 3
1.895620E-01
Grade 1-vs-Grade 4
1.234400E-01
Grade 2-vs-Grade 3
3.023400E-01
Grade 2-vs-Grade 4
2.200300E-02
Grade 3-vs-Grade 4
1.114590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.511000E-01
Normal-vs-NonDiabetic
9.488200E-01
Diabetic-vs-NonDiabetic
9.648200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.295000E-01
Normal-vs-NoPancreatitis
9.855600E-01
Pancreatitis-vs-NoPancreatitis
6.555200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.264600E-01
Normal-vs-N1
9.049200E-01
N0-vs-N1
7.108800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.723000E-01
Normal-vs-TP53-NonMutant
6.360200E-01
TP53-Mutant-vs-TP53-NonMutant
4.999000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
